Stocks · Health care · Pharmaceutical Preparations

PLIANT THERAPEUTICS, INC.

PLRX Clue Score31
United States Fiscal year ends December CIK 0001746473 Results filed 11 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Hans Hull
4 Aug 2023
Chief Business Officer
Sold after exercise
20,050
$20.01
$401.20K
Hans Hull
3 Aug 2023
Chief Business Officer
Sold after exercise
1,800
$20.00
$36.00K
Hans Hull
3 Aug 2023
Chief Business Officer
Sold after exercise
13,069
$20.00
$261.38K
Bernard Coulie
3 Feb 2023
President and CEO
Sold after exercise
5,262
$34.08
$179.31K
Bernard Coulie
3 Feb 2023
President and CEO
Sold after exercise
9,738
$33.36
$324.89K
Bernard Coulie
2 Feb 2023
President and CEO
Sold after exercise
1,605
$34.96
$56.11K
Bernard Coulie
2 Feb 2023
President and CEO
Sold after exercise
13,395
$34.13
$457.12K
Bernard Coulie
1 Feb 2023
President and CEO
Sold after exercise
105
$35.55
$3.73K
Bernard Coulie
1 Feb 2023
President and CEO
Sold after exercise
5,440
$34.78
$189.19K
Bernard Coulie
1 Feb 2023
President and CEO
Sold after exercise
9,455
$34.15
$322.84K
Bernard Coulie
31 Jan 2023
President and CEO
Sold after exercise
15,000
$34.92
$523.76K
Bernard Coulie
30 Jan 2023
President and CEO
Sold after exercise
3,605
$34.66
$124.94K
Bernard Coulie
30 Jan 2023
President and CEO
Sold after exercise
11,395
$33.98
$387.18K
Bernard Coulie
27 Jan 2023
President and CEO
Sold after exercise indirect
221
$36.64
$8.10K
Bernard Coulie
27 Jan 2023
President and CEO
Sold after exercise indirect
9,779
$35.09
$343.16K
Bernard Coulie
27 Jan 2023
President and CEO
Sold after exercise
6,302
$36.06
$227.24K
Bernard Coulie
27 Jan 2023
President and CEO
Sold after exercise
8,698
$35.42
$308.05K
Bernard Coulie
26 Jan 2023
President and CEO
Sold after exercise indirect
15,000
$35.10
$526.43K
Bernard Coulie
26 Jan 2023
President and CEO
Sold after exercise
15,000
$35.29
$529.37K
Bernard Coulie
25 Jan 2023
President and CEO
Sold after exercise
1,696
$33.29
$56.46K
Bernard Coulie
25 Jan 2023
President and CEO
Sold after exercise
13,304
$32.40
$431.06K
Bernard Coulie
24 Jan 2023
President and CEO
Sold after exercise
15,000
$30.89
$463.39K
Keith Lamont Cummings
23 Jan 2023
Chief Financial Officer
Sold after exercise
30,000
$35.00
$1.05M
Mike Ouimette
23 Jan 2023
General Counsel & Corp. Sec'y
Sold after exercise
20,000
$34.19
$683.88K
Bernard Coulie
23 Jan 2023
President and CEO
Sold after exercise indirect
15,000
$35.00
$525.00K
Bernard Coulie
23 Jan 2023
President and CEO
Sold after exercise
4,850
$34.93
$169.40K
Bernard Coulie
23 Jan 2023
President and CEO
Sold after exercise
10,150
$33.71
$342.16K
Bernard Coulie
9 Jan 2023
President and CEO
Sold after exercise
5,000
$19.17
$95.83K
Bernard Coulie
6 Jan 2023
President and CEO
Sold after exercise
15,000
$19.04
$285.58K
Bernard Coulie
4 Jan 2023
President and CEO
Sold after exercise
15,000
$19.06
$285.94K
Bernard Coulie
3 Jan 2023
President and CEO
Sold after exercise
15,000
$19.33
$289.95K
Bernard Coulie
12 Sep 2022
President and CEO
Sold after exercise
12,502
$22.54
$281.85K
Bernard Coulie
12 Jul 2022
President and CEO
Sold after exercise
12,498
$22.50
$281.21K
Bernard Coulie
11 Jul 2022
President and CEO
Sold after exercise
15,000
$22.50
$337.50K
Keith Lamont Cummings
1 Dec 2020
Chief Financial Officer
Sold after exercise
846
$30.72
$25.99K
Keith Lamont Cummings
1 Dec 2020
Chief Financial Officer
Sold after exercise
14,901
$30.21
$450.16K
Keith Lamont Cummings
1 Dec 2020
Chief Financial Officer
Sold after exercise
1,848
$29.07
$53.72K
Keith Lamont Cummings
1 Dec 2020
Chief Financial Officer
Sold after exercise
1,139
$28.24
$32.17K

What was left out

Form 4 filings counted 189
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 34
Sales straight out of an exercise 38
Sales at will 31
Transactions with no price 0
Shares from compensation/vesting 16,043,681
Sales filed before the plan box existed 31
History held since 9 Jun 2020